2308 related articles for article (PubMed ID: 2832438)
21. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486.
Luukkainen T; Heikinheimo O; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1988 Jun; 49(6):961-3. PubMed ID: 3371492
[TBL] [Abstract][Full Text] [Related]
24. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.
Hall JE; Schoenfeld DA; Martin KA; Crowley WF
J Clin Endocrinol Metab; 1992 Mar; 74(3):600-7. PubMed ID: 1740493
[TBL] [Abstract][Full Text] [Related]
25. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
26. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
Cameron ST; Thong KJ; Baird DT
Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
[TBL] [Abstract][Full Text] [Related]
27. [Mechanism of LH release with synthetic LH-RH (author's transl)].
Koyama T
Nihon Naibunpi Gakkai Zasshi; 1976 Sep; 52(9):881-97. PubMed ID: 828583
[TBL] [Abstract][Full Text] [Related]
28. Changes in the ovarian dynamics and endocrine profiles in goats treated with a progesterone antagonist during the early luteal phase of the estrous cycle.
Suganuma C; Kuroiwa T; Tanaka T; Kamomae H
Anim Reprod Sci; 2007 Oct; 101(3-4):285-94. PubMed ID: 17027203
[TBL] [Abstract][Full Text] [Related]
29. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin.
Fraser HM; Nestor JJ; Vickery BH
Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
[TBL] [Abstract][Full Text] [Related]
31. The use of anti-progesterones as a medical IUD.
Nieman LK; Loriaux DL
Baillieres Clin Obstet Gynaecol; 1988 Sep; 2(3):609-16. PubMed ID: 3233821
[TBL] [Abstract][Full Text] [Related]
32. Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration.
Dubourdieu S; Charbonnel B; Massai MR; Marraoui J; Spitz I; Bouchard P
Fertil Steril; 1991 Sep; 56(3):440-5. PubMed ID: 1894021
[TBL] [Abstract][Full Text] [Related]
33. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
34. Luteal responses to gonadotropin-releasing hormone during the luteal phase: relation to the age of corpus luteum.
Caruso A; Lanzone A; Fulghesu AM; Mancuso S
J Clin Endocrinol Metab; 1987 Feb; 64(2):274-8. PubMed ID: 3098770
[TBL] [Abstract][Full Text] [Related]
35. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
Nippoldt TB; Reame NE; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
[TBL] [Abstract][Full Text] [Related]
36. Hypothalamus-pituitary-ovarian axis in cyclic rats lacking progesterone actions.
Sánchez-Criado JE; Galiot F; Bellido C; Gonzalez D; Tébar M
Biol Reprod; 1993 Apr; 48(4):916-25. PubMed ID: 8485257
[TBL] [Abstract][Full Text] [Related]
37. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
[TBL] [Abstract][Full Text] [Related]
38. Effects of the antiprogesterone RU486 in the early follicular phase of the menstrual cycle.
Stuenkel CA; Garzo VG; Morris S; Liu JH; Yen SS
Fertil Steril; 1990 Apr; 53(4):642-6. PubMed ID: 2156736
[TBL] [Abstract][Full Text] [Related]
39. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]